Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on July 23, 2026

6 hours ago

Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201

Indeterminate GlobeNewswire

6 hours ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

6 hours ago

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Indeterminate GlobeNewswire

6 hours ago

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

Indeterminate GlobeNewswire

6 hours ago

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

Indeterminate GlobeNewswire

6 hours ago

Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions

Indeterminate GlobeNewswire

6 hours ago

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services

Indeterminate GlobeNewswire

6 hours ago

Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform

Indeterminate GlobeNewswire

6 hours ago

Revolver Brewing Becomes Revolver Beer and Spirits, Extending the Blood & Honey Brand into Whiskey, Gin and Vodka

Indeterminate GlobeNewswire

6 hours ago

BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches

Indeterminate GlobeNewswire

6 hours ago

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Indeterminate GlobeNewswire

7 hours ago

Healthcare Holding Schweiz sichert Syndikatsfinanzierung über CHF 80 Millionen

Indeterminate GlobeNewswire

7 hours ago

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

Indeterminate GlobeNewswire

7 hours ago

VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio

Indeterminate GlobeNewswire

7 hours ago

Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

7 hours ago

AAVantgarde Announces Participation of Founder and CSO, Prof. Alberto Auricchio at the 32nd Annual Meeting of the Japanese Society for Gene and Cell Therapy

Indeterminate GlobeNewswire

7 hours ago

Tilray Brands Launches ZONNA, Introducing New THC Pouches for Cannabis Consumers

Indeterminate GlobeNewswire

7 hours ago

Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026

Indeterminate GlobeNewswire

7 hours ago

Sotera Health Announces Second-Quarter 2026 Earnings Release Date

Indeterminate GlobeNewswire

7 hours ago

Commure Wins Two Stevie® Awards for Technology Excellence, Including Gold for Company of the Year in Healthcare Technology

Indeterminate GlobeNewswire